Font Size:
a
A
A
Keyword [Emission- Computed]
Result: 161 - 180 | Page: 9 of 10
161.
The Value Of
18
F-FDG PET/CT In Different Phase Of Chemotherapy For Predicting The Prognosis Of Non-Hodgkin Lymphoma
162.
Filling Gastric Cavity With Milk And Meglumini Diatrizoate Improves The Value Of
18
F-FDG PET/CT For Diagnosing The Gastric Cancer
163.
Mammography, Ultrasonography, MRI And
18
F-FDG PET-CT In Detecting The Primary Breast Malignancy Of Patients Initially Presenting As Axillary Metastasis
164.
The Value Of
18
F-FDG PET/CT Imaging In The Monitoring Of Colorectal Cancer Recurrence
165.
MRI, MPET/CT Evaluation Value Of SD Rat Model Of MCAO And MRI Studies On Brain Of Dead SD Rats
166.
Early Detection Of Cardiac Damage Using
99m
Tc-MIBI SPECT Gated Myocardial Perfusion Imaging In Patients With Esophageal Cancer During Chemoradiotherapy
167.
Studies On Tumor-targeting Positron Emission Computed Tomography Tracer Containing Sulfonamide Group
168.
The Clinical Application Value Of ECT And Laboratory Examination On The Diagnosis Of Prosthesis Joint Infection
169.
The Role Of
18
F-FMISO PET/CT In The Evaluation Of Radiosensitivity Enhancement Of Ursolic Acid In C6 Rat Glioma Model
170.
Screening Of Human Single-chain Variable Fragment Antibodies Of Medullary Thyroid Carcinomaand Single Photon Emission Computed Tomography/Computed Tomography Imaging In Tumor-bearing Nude Mice
171.
The Role Of
18
F-FDG PET/CT In Diagnosing Endometrial Cancer And Monitoring On Postoperative Endometrial Cancer
172.
Research Of Oxygen Intervention To Improve The Differential Diagnosis Value Of 99m-Methoxyisobutylisonitrile Affinity Tumor Imaging In Solitary Pulmonary Nodule
173.
Establishment And Validation Of A Diagnostic Model For Charactering Solitary Pulmonary Nodule Based On
18
F-FDG PET/CT And Clinical Data
174.
Targeting Of HER2 Overexpressing Gastric Cancer Xenograft With Site-specifically
18
F Labeled Z
HER2:342
Modified With Hydrophilic Group
175.
The Value Of
18
F-FDG PET/CT In The Diagnosis Of Solitary Pulmonary Nodules
176.
Study Of
18
F-FEA-erlotinib As An EGFR Targeting PET Imaging Agent
177.
Research On Segmentation Algorithm Of Lung Cancer PET Images Based On Visual Saliency
178.
Value Of
18
F-FDG PET-CT Imaging In Clinical Diagnosis Of Peritoneal Metastases
179.
The Value Of
18
F-FDG PET/CT Imaging In The Recurrence And Metastasis Of Post-treatment Esophageal Carcinoma
180.
Textural Analysis Of Baseline
18
F-FDG PET For Predicting Treatment Response And Prognosis In Patients With Locally Advanced Esophageal Squamous Cell Cancer
<<First
<Prev
Next>
Last>>
Jump to
